CHARLES SCHWAB INVESTMENT MANAGEMENT INC – Vertex Pharmaceuticals Incorporated Transaction History
CHARLES SCHWAB INVESTMENT MANAGEMENT INC portfolio value:
$401.86M
portfolio value
CHARLES SCHWAB INVESTMENT MANAGEMENT INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +1.75% | 23.84K shares | 17.47M | $289.54 | 1.38M |
Q2 2022 | share | Increase | +2.76% | 36.62K shares | 37.95M | $281.79 | 1.36M |
Q1 2022 | share | Increase | +5.21% | 65.77K shares | 69.36M | $260.97 | 1.32M |
Q4 2021 | share | Increase | +1.59% | 19.70K shares | 51.78M | $222.45 | 1.26M |
Q3 2021 | share | Increase | +2.10% | 25.54K shares | -19.98M | $181.39 | 1.24M |
Q2 2021 | share | Increase | +0.83% | 10.01K shares | -13.97M | $201.63 | 1.21M |
Q1 2021 | share | Decrease | -4.30% | -54.15K shares | -38.67M | $214.89 | 1.20M |
Q4 2020 | share | Decrease | -2.63% | -34.06K shares | -54.37M | $236.34 | 1.26M |
Q3 2020 | share | Increase | +4.75% | 58.73K shares | -6.49M | $272.12 | 1.29M |
Q2 2020 | share | Increase | +6.04% | 70.38K shares | 81.46M | $290.31 | 1.23M |
Q1 2020 | share | Increase | +3.27% | 36.92K shares | 30.23M | $237.95 | 1.16M |
Q4 2019 | share | Increase | +1.76% | 19.56K shares | 59.21M | $218.95 | 1.12M |
Q3 2019 | share | Increase | +3.63% | 38.79K shares | -8.36M | $169.42 | 1.10M |
Q2 2019 | share | Increase | +1.18% | 12.44K shares | 1.68M | $183.38 | 1.07M |
Q1 2019 | share | Increase | +8.06% | 78.87K shares | 32.36M | $183.95 | 1.05M |
Q4 2018 | share | Increase | 0.00% | 978.90K shares | 162.21M | $165.71 | 978.90K |
Q3 2018 | share | Increase | +2.78% | 25.20K shares | 25.52M | $192.74 | 932.41K |
Q2 2018 | share | Decrease | -6.56% | -63.72K shares | -4.05M | $169.96 | 907.20K |
Q1 2018 | share | Increase | +2.08% | 19.75K shares | 15.69M | $162.98 | 970.93K |
Q4 2017 | share | Increase | +2.82% | 26.10K shares | 1.89M | $149.86 | 951.17K |
Q3 2017 | share | Increase | +4.07% | 36.21K shares | 26.10M | $152.04 | 925.07K |
Q2 2017 | share | Increase | +20.35% | 150.31K shares | 33.78M | $128.87 | 888.85K |
Q1 2017 | share | Increase | +6.14% | 42.71K shares | 29.49M | $109.35 | 738.54K |
Q4 2016 | share | Increase | +4.00% | 26.74K shares | -7.08M | $73.67 | 695.83K |
Q3 2016 | share | Increase | +2.36% | 15.41K shares | 2.12M | $87.21 | 669.08K |
Q2 2016 | share | Increase | +2.59% | 16.51K shares | 5.58M | $86.02 | 653.67K |
Q1 2016 | share | Increase | +1.93% | 12.04K shares | -28.01M | $79.49 | 637.15K |